Joseph Brooks
Physical Medicine & Rehabilitation · Davenport, IANPI 1396904462
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $798 of the $1,208 with a category attached, or 66.1%. 8 manufacturers reported payments, led by Arthrex at 38.7% of the total. Reporting peaked in 2024 at $857 and has fallen 94.1% since, to $51 in 2025.
Across 28 payments — averaging $43.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$468
- Prism Medical$221
- Ipsen Biopharmaceuticals, Inc$197
- Merz North America, Inc.$123
- AbbVie$104
- Amgen$41
- plus $54 from 2 others
What the payments were for
- Travel & lodging$41034%
- Food & beverage$79866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $468 |
| Prism Medical | 4 | $221 |
| Ipsen Biopharmaceuticals, Inc | 7 | $197 |
| Merz North America, Inc. | 3 | $123 |
| AbbVie(2 entities) | 5 | $104 |
| Amgen | 1 | $41 |
| Vertex | 2 | $35 |
| Harmony Biosciences LLC | 1 | $20 |
How this compares
$1,208 in reported general payments places this provider in the 80th percentile of 58 physical medicine & rehabilitation providers in Iowa.
See all physical medicine & rehabilitation providers in Iowa →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $14,576 |
| Potassium Chloride | 22 | $348 |
| Metoprolol Succinate | 27 | $217 |
| Gabapentin | 21 | $205 |
| Tamsulosin Hcl | 18 | $197 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $194 |
| Carvedilol | 21 | $163 |
| Atorvastatin Calcium | 43 | $155 |
| Amlodipine Besylate | 36 | $138 |
| Losartan Potassium | 21 | $121 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $118 |
| Metoprolol Tartrate | 19 | $115 |
| Lisinopril | 35 | $97 |
| Pantoprazole Sodium | 14 | $80 |
| ClopidogrelClopidogrel Bisulfate | 19 | $59 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Davenport
- Ryan TaylorDavenport$100
- Arthur SearleDavenport$15
- Jenna RobertsonDavenport$0
- Neil SegalIowa City$2.2M
- Nicholas ApplebyCedar Rapids$49K
- Ryan KruseIowa City$8K
- Daniel GoldishNorth Liberty$6K
- Ai Huong PhuClive$6K
- Godfrey ThukuAmes$6K
- Anthony StarkDes Moines$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.